Suppression of MMP-9 expression in brain microvascular endothelial cells (BMVEC) using a gold nanorod (GNR)-siRNA nanoplex

Immunological Investigations

Volumn 41, Issue 4, 2012, Pages 337-355

  Mahajan, Supriya D ^a   Aalinkeel, Ravikumar ^a   Reynolds, Jessica L ^a   Nair, Bindukumar ^a   Sykes, Donald E ^a   Bonoiu, Adela ^b   Roy, Indrajit ^b   Yong, Ken Tye ^b   Law, Wing Cheung ^b   Bergey, Earl J ^b   Prasad, Paras N ^b   Schwartz, Stanley A ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

BMVEC; Gene silencing; Gold nano rods; MMP 9; SiRNA; Tight junctions

Indexed keywords

CLAUDIN 5; GELATINASE B; GOLD NANOROD; NANOROD; OCCLUDIN; PROTEIN ZO1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; BLOOD BRAIN BARRIER; BRAIN MICROVASCULAR ENDOTHELIAL CELL; CELL MIGRATION; CELL VIABILITY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MEMBRANE PERMEABILITY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; STATIC ELECTRICITY; TIGHT JUNCTION;

BRAIN; CELL SURVIVAL; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENE SILENCING; HUMANS; MATRIX METALLOPROTEINASE 9; MICROVESSELS; NANOTUBES; PARTICLE SIZE; RNA, SMALL INTERFERING; STATIC ELECTRICITY; TIGHT JUNCTIONS; TRANSFECTION;

EID: 84862515468     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820139.2011.604863     Document Type: Article

References (36)

1. Abbott, N. (2005). Dynamics of CNS barriers: Evolution, differentiation, and modulation. Cell. Mol. Neurobiol. 25:5-23.
2. Abbott, N. J. (2004). Prediction of blood-brain barrier permeation in drug discovery from in vivo, in vitro and in silico models. Drug Discov. Today: Technol. 1:407-416.
3. Alvarez, J. I., Teale, J. M. (2006). Breakdown of the blood brain barrier and bloodcerebrospinal fluid barrier is associated with differential leukocyte migration in distinct compartments of the CNS during the course of murine NCC. J. Neuroim - munol. 173:45-55.
4. Asahi, M., Sumii, T., Fini, M. E., Iltohara, S., Lo, E. H. C. (2001). Matrix metalloproteinase 2 gene knockout has no effect on acute brain injury after focal ischemia. Neuropharmacol. Neurotoxicol. 12:3003-3007.
5. Bernacki, J., Dobrowolska, A., Nierwińska, K., Małecki, A. (2008). Physiology and pharmacological role of the blood-brain barrier. Pharmacol. Rep. Sep-Oct; 60(5):600-622.
6. Bonoiu, A., Mahajan, S. D., Ye, L., Kumar, R., Ding, H., Yong, K. T., Roy, I., Aalinkeel, R., Nair, B., Reynolds, J. L., Sykes, D. E., Imperiale, M. A., Bergey, E. J., Schwartz, S. A., Prasad, P. N. (2009a). MMP-9 gene silencing by a quantum dotsiRNA nanoplex delivery to maintain the integrity of the blood brain barrier. Brain Res. Jul. 28;1282:142-155.
7. Bonoiu, A. C., Mahajan, S. D., Ding, H., Roy, I., Yong, K. T., Kumar, R., Hu, R., Bergey, E. J., Schwartz, S. A., Prasad, P. N. (2009b). Nanotechnology approach for drug addiction therapy: Gene silencing using delivery of gold nanorod-siRNA nanoplex in dopaminergic neurons. Proc. Natl. Acad. Sci. USA 106(14):5546-5550.
8. Boven, L. A., Middel, J., Verhoef, J., De Groot, C. J., Nottet, H. S. (2000). Monocyte infiltration is highly associated with loss of the tight junction protein zonula occludens in HIV-1-associated dementia. Neuropathol. Appl. Neurobiol. 26(4):356-360.
9. Bustin, S. A. (2002). Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): Trends and problems. J. Mol. Endocrinol. 1:23-39.
10. Cardona, A. E., Li, M., Liu, L., Savarin, C., Ransohoff, R. M. (2008). Chemokines in and out of the central nervous system: much more than chemotaxis and inflammation. J. Leukoc. Biol. 84(3):587-594.
11. Daneman, R., Zhou, L., Agalliu, D., Cahoy, J. D., Kaushal, A., Barres, B. A. The mouse blood-brain barrier transcriptome: a new resource for understanding the development and function of brain endothelial cells. PLoS One. Oct. 29;5(10):e13741.
12. Davis, M. E., Zuckerman, J. E., Choi, C. H., Seligson, D., Tolcher, A., Alabi, C. A., Yen, Y., Heidel, J. D., Ribas, A. (2010). Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 464(7291):1067-1070.
13. Davis, M. E. (2009) The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic. Mol. Pharm. 6(3):659-668.
14. Hauck, T. S., Ghazani, A. A., Chan, W. C. (2008). Assessing the effect of surface chemistry on gold nanorod uptake, toxicity, and gene expression in mammalian cells. Small 4(1):153-159.
15. Lee, S. R., Kim, H., Rogowska, J., Zhao, B., Bhide, P., Parent, J. M., Lo, E. H. (2006). Involvement of matrix metalloproteinase in neuroblast cell migration from the subventricular zone after stroke. J. Neurosci. 6(13):3491-3495.
16. Li, J., Chen, Y.-C., Tseng, Y.-C., Mozumdar, S., Huang, L. (2010). Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery; Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery. J. Control. Rel. 142:416-421.
17. Li, S.-D., Huang, L. (2009). Nanoparticles evading the reticuloendothelial system: Role of the supported bilayer. Biochim. Biophys. Acta - Biomembranes 1788:2259-2266.
18. Patel MM, Goyal BR, Bhadada SV, Bhatt JS, Amin AF. (2009). Getting into the brain: Approaches to enhance brain drug delivery. CNS Drugs 23(1):35-58.
19. Paul, R., Lorenzl, S., Koedel, U., Sporer, B., Vogel, U., Frosch, M., Pfister, H. W. (1998). Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis. Ann.-Neurol. 44:592-600.
20. Persidsky, Y., Ramirez, S. H., Haorah, J., Kanmogne, G. D. (2006). Blood-brain barrier: structural components and function under physiologic and pathologic conditions. J. Neuroimmun. Pharmacol. Sep; 1(3):223-236.
21. Persidsky, Y., Gendelman H. E. (1997). Development of laboratory and animal model systems for HIV-1 encephalitis and its associated dementia. J. Leukoc. Biol. 62:100-106.
22. Persidsky, Y., Stins, M., Way, D., Witte, M. H., Weinand, M., Kim, K. S., Bock, P., Gendelman, H. E., Fiala, M., (1997). A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis. J Immunol. 158:3499-3510.
23. Prasad, P. N. (2003). Introduction in Biophotonics. Wiley, New York.
24. Prasad, P. N. (2004). Nanophotonics. Wiley, New York.
25. Qiu, Y., Liu, Y., Wang, L., Xu, L., Bai, R., Ji, Y., Wu, X., Zhao, Y., Li, Y., Chen, C. (2010). Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods. Biomaterials 31(30):7606-7619.
26. Radonić, A., Thulke, S., Mackay, I. M., Landt, O., Siegert, W., Nitsche, A. (2004). Guideline to reference gene selection for quantitative real-time PCR. Biochem Biophys Res Commun. 313:856-862.
27. Rosell, A., Ortega-Aznar, A., Alvarez-Sabin, J., Fernandez-Cadenas, I., Ribo, M., Molina, C. A., Lo, E. H., Montaner, J. (2006). Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke. Stroke 37(6):1399-1406.
28. Rosenberg, G. A. (2002). Matrix metalloproteinases in neuroinflammation. Glia 39:279-291.
29. Rosenberg, G. A. (2009). Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol. Feb; 8(2):205-216.
30. von Wedel-Parlow, M., Schrot, S., Lemmen, J., Treeratanapiboon, L., Wegener, J., Galla, H. J. (2010). Neutrophils cross the BBB primarily on transcellular pathways: An in vitro study. Brain Res. Jan 7;1367:62-76.
31. Wang, X., Jung, J., Asahi, M., Chwang, W., Russo, L., Moskowitz, M. A., Dixon, C. E., Fini, M. E., Lo, E. H. (2000). Effects of matrix metalloproteinase-9 gene knock-out on morphological and motor outcomes after traumatic brain injury. J. Neurosci. 20:7037-7042.
32. Woessner Jr, F. (1991). Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5:2145-2154.
33. Wu, D. T., Woodman, S. E., Weiss, J. M., Mc, M. C. M., D'Aversa T. G., Hesselgesser, J., Major, E. O., Nath, A., Berman, J. W. (2000). Mechanisms of leukocyte trafficking into the CNS. J. Neurovirol. Suppl 1:S82.
34. Yong, K. T., Roy, I., Ding, H., Bergey, E. J., Prasad, P. N. (2009). Biocompatible nearinfrared quantum dots as ultrasensitive probes for long-term in vivo imaging applications. Small. 5(17):1997-2004.
35. Yong, V. W., Power, C., Forsyth, P., Edwards, D. R. (2001) Metalloproteinases in biology and pathology of the nervous system. Nat. Rev. Neurosci. 2:502-511.
36. Yong, K. T., Qian, J., Roy, I., Lee, H., Bergey, E., Tramposch, K., He, S., Swihart, M., Maitra, A., Prasad, P. (2007). Quantum rod bioconjugates as targeted probes for confocal and two-photon fluorescence imaging of cancer cells. Nano. Lett. 7:761-765.